Roopashri Melkote
About Roopashri Melkote
Roopashri Melkote is a Senior Specialist in QC Cell Therapy at Bristol Myers Squibb, with a background in microbiology and business management.
Current Role at Bristol Myers Squibb
Roopashri Melkote is currently serving as a Senior Specialist in QC Cell Therapy at Bristol Myers Squibb, located in Summit, New Jersey, United States. She has been working in the field of cell therapy quality control since November 2020. In her role, she is involved in ensuring the quality and compliance of cell therapy products, leveraging her extensive background in microbiology and business management to meet industry standards and regulatory requirements.
Previous Experience at OPS Diagnostics
Before her current role, Roopashri Melkote worked at OPS Diagnostics as a QA Manager from 2019 to 2020. During her 11 months in Lebanon, New Jersey, she focused on quality assurance, implementing and maintaining quality management systems to ensure product reliability and compliance with industry standards.
Leadership Role at MCR TECHNOLOGIES, INC.
Roopashri Melkote held the position of Director at MCR TECHNOLOGIES, INC. from 2015 to 2019. Over her four-year tenure in the United States, she oversaw various operations, developing and implementing strategies to drive company performance. Her responsibilities included managing teams, optimizing processes, and enhancing operational efficiency.
Educational Background in Microbiology and Business Administration
Roopashri Melkote's academic credentials include a Bachelor of Applied Science (BASc) in Microbiology, General, from Bangalore University and a Master of Business Administration (MBA) in Business, Management, Marketing, and Related Support Services from Newport University. This combination of scientific and business education has equipped her with a unique blend of skills, allowing her to excel in roles that require both technical knowledge and strategic management capabilities.